Home Press Releases Biological Drugs Market to Expand at a CAGR of 10.1% to 2020 Due to Rise in Chronic Diseases
Biological Drugs Market to Expand at a CAGR of 10.1% to 2020 Due to Rise in Chronic Diseases
Posted on Jun 9, 2015
Transparency Market Research has released a latest market research report titled “Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014-2020”. The report examines the global industry for biological drugs, reports on the market trends, drivers, future prospects and goes into the details of market segments and the restraints for the biological drugs market.According to the report, the global biological drugs market is developing at an encouraging CAGR of 10.1% during the forecast period from 2014 to 2020. The global biological drugs market was valued at US$161,056.5 million in 2014 and is predicted to reach a value of US$ 287,139.7 million by 2020. There is augmented growth in the biological drugs market globally as a result of high occurrences of chronic diseases. Biological drugs are used to treat and prevent auto-immune diseases, blood related diseases, cancer, and various medical disorders.
The report discusses the market drivers and restraints for biological drugs in detail. The high incidence of chronic diseases, government initiatives, and rise in geriatric population have all contributed to the accelerated growth of the biological drugs market. Other market growth factors include the advancement of biomedical science due to research that is supported and funded by public and private organizations as well as new enhanced drugs in the market. The factors that inhibit market expansion for biological drugs include risks linked with injectable biological medicines, patent expiry of various biological drugs, and high cost of biological drugs.Trends in the biological drugs market indicate the use of anti-vascular endothelial growth factor (VEGF) therapy in biopharmaceutical industry and genetically modified organisms (GMOs).
The market report explains the various segments within the biological drugs market. The segments are created on the basis of therapeutic protein, monoclonal antibody, vaccines, and geographical region. The therapeutic protein segment includes: Enbrel, Rebif, Aranesp, Epogen, Victoza, Neupogen, Eylea, Levemir, Rebif, Lantus, Avonex, Humalog, Betaseron, Neulasta and Novolog. Of these, Enbrel has the largest and rapidly growing market share as of 2014 within the therapeutic protein segment of the biological drugs market.
The vaccine segment includes Cervarix, Fluzone, Varivax, Prenvar 13 and Gardasil. Among these, Prenvar 13 is seen to be the fastest developing segment. The monoclonal antibody (mAb) segment includes Lucentis, Avastin, Remicade, Humira, Herceptin, Rituxan and Remicade. In this segment, Humira is reported as the fastest growing biological drug.The global biological drug market is also divided based on the following geographical areas: North America, Europe, Asia, and Rest of World (Row). North America had the largest market share in 2014. The report discusses the pipeline of biological drugs in the development phase over the forecast period. This includes drugs for treating blood diseases, cancer and related conditions, diabetes and cardiovascular diseases, and auto-immune diseases.
Browse the full Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/biological-drugs-market.html
The report provides descriptive details of major players in the biological drug market with a company overview, products and segments, financial performance, and strategic developments. The companies are Novartis AG, Eli Lilly and Company, GlaxoSmithKline Plc., Merck & Co., Inc., Abbott Laboratories, Bristol-Myers Squibb Company, Biogen Idec, Amgen Inc., Baxter International Inc., and Pfizer Inc.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
Share This Article!
- Nuclear Medicine/Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
- Nuclear medicines are the the drugs containing radioactive material (radionuclide-emmitting ionizing radiations)for the diagnosis and treatmentof various diseases. Radiopharmaceuticals targetsthe organ or specific site and emitsthe gamma radiations which are captured by external gamma cameras. However, dose of radiations is kept low to avoid the side effects. These radiopharmaceuticals are administered...
- Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023Autoimmune disease refers to a medical disorder characterized by inflammatory reactions caused by the overactive immune response of the body resulting in the actions against own cells and body tissues. There are more than 80 types of autoimmune diseases and are known to be more prevalent in women than men. According to the National Institute of Health (NIH), autoimmune diseases are ranked amongst the top ten causes of death in women in the U.S. Autoimmune...
- Protein Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023Protein engineering is defined as the process for the development of new, valuable and useful proteins. Protein engineering can be achieved with two techniques, namely directed evaluation and rational protein designing. Proteins possess a dynamic ability of less immunogenicity and high specificity. Using this ability, proteins can be engineered in such a way that they can be used as therapeutic agents. Owing to the technological advancements, unnatural...